Glutamate exacerbates amyloid β1-42-induced impairment of long-term potentiation in rat hippocampal slices

Japanese Journal of Pharmacology

Volumn 88, Issue 2, 2002, Pages 223-226

  Nakagami, Yasuhiro ^a   Oda, Tomiichiro ^a  

^a DAIICHI SANKYO CO   (Japan)

Author keywords

Amyloid ; Glutamate; Long term potentiation

Indexed keywords

AMYLOID BETA 1 42 PROTEIN; AMYLOID BETA PROTEIN; GLUTAMIC ACID; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG EXPOSURE; DRUG INHIBITION; HIPPOCAMPUS; LONG TERM POTENTIATION; MALE; NERVE CELL EXCITABILITY; NEUROTOXICITY; NONHUMAN; RAT; SENILE PLAQUE;

EID: 0036125305     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.88.223     Document Type: Article

References (15)

1. Alzheimer's disease: Genes, proteins, and therapy
2. Neurodegeneration induced by β-amyloid peptides in vitro: The role of peptide assembly state
3. Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain
4. Impairments of long-term potentiation in hippocampal slices of beta-amyloid-infused rats
5. Ionic dependence of glutamate neurotoxicity
6. β-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity
7. Co-injection of β-amyloid with ibotenic acid induces synergistic loss of rat hippocampal neurons
8. LTP mechanisms: From silence to four-lane traffic
9. Suppression of mitochondrial succinate dehydrogenase, a primary target of β-amyloid, and its derivative racemized at Ser residue
10. Laminin degradation by plasmin regulates long-term potentiation
11. Bilateral injections of βA(25 - 35) + IBO into the hippocampus disrupts acquisition of spatial learning in the rat
12. Amyloid β-protein activates tachykinin receptors and inositol trisphosphate accumulation by synergy with glutamate
13. Superoxide free radical and intracellular calcium mediate Aβ(1 - 42) induced endothelial toxicity
14. Targeting small Aβ oligomers: The solution to an Alzheimer's disease conundrum?
15. Diffusible, nonfibrillar ligands derived from Aβ1 - 42 are potent central nervous system neurotoxins